.1 Structure of side-chain groups (R) of amino acids except for proline, for which the entire structure is presented. Figure 8.2 The tagging of a protein molecule with ubiquitin to identify it for degradation. Three enzymes are involved: (i) E 1 is activated by binding to ubiquitin (ii) E 2 displaces E 1 (iii) E 3 catalyses the transfer of ubiquitin from E 2 to the 'doomed' protein: more than one molecule is transferred to produce multi-ubiquitinated protein, which is the ideal substrate for the proteolytic enzyme. Figure 8 .3 A summary of pathways involved in the synthesis of non-essential amino acids. Glutamate is produced from ammonia and oxoglutarate. Glutamate is the source of nitrogen for synthesis of most of the amino acids. Cysteine and tyrosine are different because they require the essential amino acids (methionine and phenylyalanine) for their synthesis. These two amino acids are, therefore, conditionally essential, i.e. when there is not sufficient methionine or phenylyalanine for their synthesis, they are essential (Details are in Appendix 8.2). Figure 8 .4 General summary of metabolism of amino acids. Amino acids in blood can be derived from the diet or hydrolysis of endogenous protein. The nitrogen in the amino acids can be used to synthesise other nitrogen-containing compounds (e.g. glutamine - see Table 8 .4) or removed as urea (Chapter 10). The amino acids are also used to synthesise proteins or peptides. The carbon can be converted to CO 2 , glucose or triacylglycerol, but, in humans, very little is converted into fat, so triacylglycerol is omitted from the figure. Figure 8 .5 Active amino acid transport into cells. Amino acids are transported into cells against their concentration gradient coupled to Na + ion transport down its concentration gradient. The Na + ion is transported out in exchange for K + -ions, via the Na + /K + ATPase, Chapter 5). Figure B2 (i) The pathway for conversion of proline and alanine in the flight muscle of the tsetse fly: the major ATP-generating pathway. Alanine aminotransferase is essential for the proline oxidation pathway in order for glutamate to enter the Krebs cycle as oxoglutarate and pyruvate to be converted to alanine, the end of the pathway. It is assumed that the pathway is the same for the Colorado beetle, but no studies have been reported. Figure 8 .7 Simplified summary of degradation of 21 amino acids. The 21 amino acids are degraded to six different common intermediates that are further metabolised to produce only three end-products (CO 2 , glucose or fat). The ATP produced from oxidation of half of the amino acids is used to synthesise glucose from the other half of the amino acids. This is a general metabolic point, it does not apply in all conditions: the ATP can be used in other processes (e.g. urea cycle). In starvation, ATP is generated from fat oxidation, since oxoacids are not oxidised but are converted to glucose. Figure 8 .10 A summary of the processes involved in transdeamination. (1) transamination (2) glutamate dehydrogenase. The glutamate dehydrogenase reaction results in ammonia production. The oxoacids are further metabolised to CO 2 , glucose or fat. (1) digestion of protein in the intestine and absorption of resultant amino acids, (2) degradation of endogenous protein to amino acids (primarily but not exclusively muscle protein), (3) protein synthesis, (4) conversion of amino acid to other nitrogen-containing compounds (see Table 8 .4), (5) oxidation to CO 2 , (6) conversion to glucose via gluconeogenesis, (7) conversion to fat. (1) other nitrogen-containing compounds, e.g. essential proteins or peptides, amino acids, such as glutamine; (2) glucose, especially if anorexia is present. It is likely that, in starvation and trauma, some protein synthesis occurs, for example, to replace damaged proteins. Figure 8 .15 A plot of leucine oxidation against leucine intake. The plot illustrates a linear relationship between leucine intake and oxidation. The leucine intake is calculated from the protein intake. It is assumed that the same relationship would hold for other amino acids. A similar response is seen for urea production. Data from Young et al., 2000 . Figure 8 . 16 The control of amino acid breakdown and protein synthesis in liver. The factors in regulation are as follows: (i) the amino acid concentration in the blood regulates the rate of urea production (Chapter 10); (ii) the amino acid leucine, and the anabolic hormones increase the rate of protein synthesis. Mass action is a term used to describe the effect of concentration of substrate on the reaction rate. The control of protein synthesis is discussed in Chapter 20. Control by leucine has been studied primarily in muscle. Figure 8.17 The metabolism of branched-chain amino acids in muscle and the fate of the nitrogen and oxoacids. The α-NH 2 group is transferred to form glutamate which is then aminated to form glutamine. The ammonia required for amination arises from glutamate via glutamate dehydrogenase, but originally from the transamination of the branded chain amino acids. Hence, they provide both nitrogen atoms for glutamine formation. Figure 8.18 The role of the intestine and kidney in formation of arginine. The intestine converts arginine to citrulline, to be released into the blood to be taken up by the kidney where it is converted to arginine. An important role of arginine is conversion to nitric oxide, a key messenger molecule, and neuromodulator in the brain (Chapter 14). Figure 8.19 The formation of glutathione. Glutathione is an important peptide especially in removal of free radicals (i.e. as an antioxidant). It is synthesised in the intestine from glutamate, cysteine and glycine (see Appendix 8.4 for details). Figure 8.20 (a) The synthesis of phosphocreatine. The compound guanidinoacetate is formed from arginine and glycine in the kidney and is then transported to the liver where it is methylated addition of 'CH 3 ' (see Chapter 15) to form creatine (see Appendix 8.4 for details). Creatine is taken up by tissues/organs/cells and phosphorylated to form phosphocreatine, particularly in muscle. (b) Conversion of phosphocreatine and creatine to creatinine in muscle. Creatinine is gradually formed and then released into blood and excreted in urine. Figure 8.21 The amino acids that are precursors for neurotransmitters in the brain. These are discussed in Chapter 14. Figure 8.22 The glutamate/glutamine shuttle for provision of the glutamate neurotransmitter in the brain. This illustrates another role for glial cells in the brain. Figure 8 .23 Formation of glutamine from glucose and branched-chain amino acids in muscle and adipose tissue and probably in the lung. Oxoacids may also be released into blood for oxidation in the liver. Figure 8 .24 Some fates of glutamine that is released by muscle. Glutamine is released from the store of glutamine in the muscle but, for immune system and bone marrow, it may also be provided from adipocytes (Chapter 17). It is assumed that glutamine is present as a free amino acid in muscle and that there is a specific transport protein in the plasma membrane that can be regulated. Figure 8.25 Excess ammonia in the muscle is used to form alanine. Ammonia is released from several reactions and is incorporated into alanine via glutamate dehydrogenase and transamination. OG - oxoglutarate. Alanine is released into the blood from volece it is removed by the liver. Figure 8 .26 Fate of glutamine in the kidney. Glutamine is converted to oxoglutarate releasing two molecules of ammonia. The fate of the oxoglutarate is, in the fed condition, oxidation to CO 2 to generate ATP. In starvation, it is converted to glucose via gluconeogenesis. The quantitative importance of the kidney to provide glucose, in comparison with the liver, is not known but it may be significant. Figure 8 .27 Pathway of glutamine metabolism in the intestinal cells. Glutamine is metabolised to alanine to generate ATP: alanine is released into the blood to be taken up by the liver. Figure 8 .28 Metabolic fate of glutamine in immune cells. Glutamine is converted to glutamate and then to oxoglutarate which is converted to oxaloacetate. Enzymes are as follows: (1) glutaminase, (2) glutamate dehydrogenase, (3) oxoglutarate dehydrogenase, (4) succinyl-CoA transferase, (5) succinate dehydrogenase, (6) fumarase, (7) malate dehydrogenase, (8) aspartate aminotransferase. The pathway is presented in such a way as to indicate that conversion of oxoglutarate to oxaloacetate is part of the Krebs cycle. The pathway is known as glutaminolysis. Figure 8.29 The initial reactions of glutamine metabolism in kidney, intestine and cells of the immune system. The initial reaction in all these tissues is the same, glutamine conversion to glutamate catalysed by glutaminase: the next reactions are different depending on the function of the tissue or organ. In the kidney, glutamate dehydrogenase produces ammonia to buffer protons. In the intestine, the transamination produces alanine for release and then uptake and formation of glucose in the liver. In the immune cells, transamination produces aspartate which is essential for synthesis of pyrimidine nucleotides required for DNA synthesis: otherwise it is released into the blood to be removed by the enterocytes in the small intestine or by cells in the liver. Figure 8 .30 Different roles of periportal and perivenous cells in the liver in respect of glutamine metabolism. Glutamine is converted to glucose in periportal cells via gluconeogenesis: in perivenous cells, ammonia is taken up, to form glutamine, which is released into the blood. This emphasises the importance of the liver in removing ammonia from the blood, i.e. if possesses two process to ensure that all the ammonia is removed. Figure 8 .31 Comparison of glutamine as a fuel in the blood with glucose and fatty acids. The concentration of glutamine in the blood is similar to that of fatty acid. The amount of glutamine stored in muscle is similar to the amount of glycogen stored in the liver; that is, about 80 g. Mobilisation of each of these stored fuels is discussed in Chapters 6, 7, 17 and 18. It appears that glutamine is stored free in the cytosol. Polyglutamine on vesicles containing glutamine have not been found. Figure 8 .32 Urea salvage in humans. Urea diffuses into the colon where it is converted to ammonia in those microorganisms that possess the enzyme urease. The ammonia is used by most microorganisms in the colon to synthesise their protein. Upon death in the colon, these organisms are degraded and the protein is hydrolysed to amino acids, some of which are absorbed by the host to be used for protein synthesis, etc. Photograph kindly provided by Dr. Caroline Pond (Open University, UK)
